Orchid Cellmark To Announce Second Quarter 2008 Financial Results on July 31, 2008

Date : 07/24/2008 @ 7:00AM
Source : PR Newswire
Stock : Orchid Cellmark Inc. (MM) (ORCH)
Quote : 1.55  0.08 (5.44%) @ 8:00PM
<< BackQuote Chart Financials

 



Orchid Cellmark To Announce Second Quarter 2008 Financial Results on July 31, 2008

PRINCETON, N.J., July 24 /PRNewswire-FirstCall/ -- Orchid Cellmark Inc. (NASDAQ:ORCH), a leading worldwide provider of identity DNA testing services, will release its second quarter 2008 financial results on Thursday, July 31, 2008 at approximately 7:00 a.m. EDT, and is hosting a conference call and webcast to discuss the results at 10:00 a.m. EDT on the same day. Management will discuss financial results for the second quarter 2008 as well as operating highlights. A question-and-answer session will follow management's discussion. All interested parties are encouraged to listen to the live conference call or the live or archived webcast.

Conference Call Details

Date and Time: Thursday, July 31, 2008 at 10:00 a.m. EDT

Dial-In: US/Canada: (877) 266-0703 Int'l/Local: (706) 643-7682 Conference ID: 57573304

Webcast: Live webcast and replay available via the Investor Relations section of the company's website at http://www.orchidcellmark.com/. The webcast will be available for 90 days.

About Orchid Cellmark

Orchid Cellmark (NASDAQ:ORCH) is a leading international provider of DNA testing services primarily for forensic and family relationship applications. Orchid Cellmark is one of the largest providers of forensic DNA testing services and its DNA results are used by the criminal justice system to assist with the identification of perpetrators, the exclusion of suspects and the exoneration of wrongfully convicted individuals. The company provides DNA family relationship testing to numerous child services organizations and individuals seeking to verify parentage. Orchid Cellmark also serves immigration and security authorities for DNA testing of individuals. In the agriculture field, the company provides DNA testing services for selective trait breeding. Orchid Cellmark's strong market positions in these areas reflect the company's accredited laboratories in the U.S. and U.K., its innovative genetic analysis technologies and expertise, and the company's reputation for exceptional quality, reliability and customer service for nearly two decades. More information on Orchid Cellmark can be found at http://www.orchidcellmark.com/.

Contact: Investors: Media: Mary Bashore Rick Anderson Orchid Cellmark Inc. The Torrenzano Group (609) 750-2324 (212) 681-1700

DATASOURCE: Orchid Cellmark Inc.

CONTACT: Investors: Mary Bashore of Orchid Cellmark Inc.,

+1-609-750-2324, ; Media: Rick Anderson of The Torrenzano Group,

+1-212-681-1700,

Web site: http://www.orchid.com/

<< Back


Orchid Cellmark Inc. (MM) Historical Chart Orchid Cellmark Inc. (MM) Intraday Chart  
Period


LSE and PLUS quotes are live. NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Request an Exchange :: Affiliate Scheme
Copyright1999-2008 ADVFN PLC. Copyright and limited reproduction :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs
ADDITIONAL SERVICES AVAILABLE FROM ADVFN
Upgrade - Click here for more information on ADVFN premium services Money Words - ADVFN Financial Glossary Investor Training ADVFN Financial Bookshop Online Training Academy
36 site:2us 081011 16:11 Stock Message Boards ( 2001 | 2002 | 2003 | 2004 | 2005 | 2005 | 2007 )